BioScrip Inc (BIOS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioScrip Inc (BIOS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7156
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that provides infusion care services. The hospital offers a range of infusion services, PBM services and respiratory services. It provides infusion therapy services such as antimicrobial drugs, factor replacement therapy for hemophilia, hepatitis therapy, biologic agents, monoclonal antibodies, inotropic therapy for late stage heart failure, pain management and other injectable therapies, among others. BioScrip also offers oxygen therapy, CPAP and Bi-level therapy, ventilator therapy and tracheostomy therapy equipment, among others. The hospital has operations in Alabama, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Massachusetts, Maine, Minnesota, North Carolina, and others. BioScrip is headquartered in Denver, Colorado, the US.

BioScrip Inc (BIOS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioScrip Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioScrip Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioScrip Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioScrip Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioScrip Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioScrip Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Bioscrip Raises USD5 Million in Private Placement of Shares 10
BioScrip Completes Public Offering Of Common Stock For US$119 Million 11
Debt Offering 13
BioScrip Completes Private Placement Of Notes Due 2021 For US$200 Million 13
BioScrip Inc – Key Competitors 14
BioScrip Inc – Key Employees 15
BioScrip Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 08, 2018: BioScrip Reports Fourth Quarter and Full Year 2017 Financial Results 19
Corporate Communications 21
Jul 10, 2018: BioScrip Names Richard Denness As Chief Commercial Officer 21
Legal and Regulatory 22
Feb 09, 2018: BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
BioScrip Inc, Medical Equipment, Key Facts, 2017 2
BioScrip Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioScrip Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioScrip Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioScrip Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioScrip Inc, Deals By Market, 2012 to YTD 2018 8
BioScrip Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bioscrip Raises USD5 Million in Private Placement of Shares 10
BioScrip Completes Public Offering Of Common Stock For US$119 Million 11
BioScrip Completes Private Placement Of Notes Due 2021 For US$200 Million 13
BioScrip Inc, Key Competitors 14
BioScrip Inc, Key Employees 15
BioScrip Inc, Other Locations 16
BioScrip Inc, Subsidiaries 17

List of Figures
BioScrip Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioScrip Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioScrip Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioScrip Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioScrip Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioScrip Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioScrip Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioScrip Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioScrip Inc (BIOS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jefferies Group LLC:企業の戦略・SWOT・財務情報
    Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report Summary Jefferies Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Swift Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Fate Therapeutics Inc (FATE):企業の財務・戦略的SWOT分析
    Fate Therapeutics Inc (FATE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Pharmaceutical Product Development LLC:企業の戦略的SWOT分析
    Pharmaceutical Product Development LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …
  • Acadia Pharmaceuticals Inc (ACAD):製薬・医療:M&Aディール及び事業提携情報
    Summary Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system disorders. The company’s lead product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. Acadia also de …
  • IJM Land Berhad:企業の戦略・SWOT・財務情報
    IJM Land Berhad - Strategy, SWOT and Corporate Finance Report Summary IJM Land Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Accord Financial Corp. (ACD):企業の財務・戦略的SWOT分析
    Accord Financial Corp. (ACD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • HP Inc.:企業の戦略・SWOT・財務情報
    HP Inc. - Strategy, SWOT and Corporate Finance Report Summary HP Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Banco Nacional de Obras y Servicios Publicos SNC:企業の戦略・SWOT・財務情報
    Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report Summary Banco Nacional de Obras y Servicios Publicos SNC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Lotus Pharmaceutical Co Ltd (1795):企業の財務・戦略的SWOT分析
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Balkrishna Industries Ltd:企業の戦略・SWOT・財務情報
    Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Balkrishna Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • KARL STORZ GmbH & Co KG-医療機器分野:企業M&A・提携分析
    Summary KARL STORZ GmbH & Co KG (Karl Storz) is a manufacturer and distributor of endoscopes, surgical devices and medical instruments. The company offers rigid and flexible endoscopes, instruments for the field of human medicine used for neurosurgery; oral and maxillofacial surgery; ear, nose, and …
  • Deutsche Borse Ag:企業の戦略・SWOT・財務分析
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Perenco Holdings:石油・ガス:M&Aディール及び事業提携情報
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • China Shipbuilding Industry Corp:企業の戦略・SWOT・財務情報
    China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Convergys Corporation:企業の戦略・SWOT・財務情報
    Convergys Corporation - Strategy, SWOT and Corporate Finance Report Summary Convergys Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆